NCT01196936 2026-01-05
LDTam
University of Alabama at Birmingham
Phase 2 Active not recruiting
Clinical Trials
7 trialsNCT00665457 2023-09-13
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
University of Nebraska
Phase 2 Terminated
NCT00873366 2018-01-23
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
Mayo Clinic
Terminated
NCT00764322 2017-08-01
NRR
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT00967239 2015-05-08
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NSABP Foundation Inc
Unknown
NCT01071564 2015-04-15
RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00645866 2011-05-16
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
Mayo Clinic
Phase 2 Completed